13F HOLDINGS REPORT
Opaleye Management Inc.
Quarter ended Q1 2023 · Filed February 10, 2023 · Accession 0001493152-23-004277
Total Value
$287.4M
Positions
40
Other Managers
0
Confidential Omitted
No
Holdings (40)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | HARROW HEALTH INC | HROW | 3,775,000 | $55.7M | 19.38% |
| 2 | TELA BIO INC | TELA | 2,072,813 | $23.8M | 8.29% |
| 3 | RHYTHM PHARMACEUTICALS INC | RYTM | 735,000 | $21.4M | 7.44% |
| 4 | OCULAR THERAPEUTIX INC | OCUL | 6,075,000 | $17.1M | 5.94% |
| 5 | CRINETICS PHARMACEUTICALS INC | CRNX | 732,000 | $13.4M | 4.66% |
| 6 | CYTOKINETICS INC | CYTK | 250,000 | $11.5M | 3.98% |
| 7 | KEROS THERAPEUTICS INC | KROS | 238,000 | $11.4M | 3.97% |
| 8 | VAXCYTE INC | PCVX | 177,000 | $8.5M | 2.95% |
| 9 | BIOHAVEN LTD | BHVN | 540,000 | $7.5M | 2.61% |
| 10 | 4D MOLECULAR THERAPEUTICS INC | FDMT | 330,000 | $7.3M | 2.55% |
| 11 | PROTARA THERAPEUTICS INC | TARA | 2,692,594 | $7.2M | 2.51% |
| 12 | TRACON PHARMACEUTICALS INC | 89237H209 | 4,590,000 | $6.8M | 2.38% |
| 13 | LARIMAR THERAPEUTICS INC | LRMR | 1,560,000 | $6.4M | 2.24% |
| 14 | KALVISTA PHARMACEUTICALS INC | KALV | 923,200 | $6.2M | 2.17% |
| 15 | ETON PHARMACEUTICALS INC | ETON | 2,170,000 | $6.1M | 2.13% |
| 16 | EDGEWISE THERAPEUTICS INC | EWTX | 611,400 | $5.5M | 1.90% |
| 17 | PROQR THERAPEUTICS NV | N71542109 | 1,460,000 | $5.4M | 1.88% |
| 18 | PHATHOM PHARMACEUTICALS INC | PHAT | 417,500 | $4.7M | 1.63% |
| 19 | XOMA CORP DEL | XOMAP | 243,000 | $4.5M | 1.55% |
| 20 | CODEXIS INC | CDXS | 957,500 | $4.5M | 1.55% |
| 21 | UROGEN PHARMA LTD | URGN | 488,656 | $4.3M | 1.51% |
| 22 | KARYOPHARM THERAPEUTICS INC | KPTI | 1,206,841 | $4.3M | 1.49% |
| 23 | ASTRIA THERAPEUTICS INC | 04635X102 | 261,703 | $3.9M | 1.36% |
| 24 | LIQUIDIA CORPORATION | LQDA | 560,000 | $3.6M | 1.24% |
| 25 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 167,500 | $3.4M | 1.17% |
| 26 | MARINUS PHARMACEUTICALS INC | 56854Q200 | 826,200 | $3.3M | 1.14% |
| 27 | EDAP TMS S A | EDAP | 306,713 | $3.3M | 1.14% |
| 28 | AADI BIOSCIENCE INC | WHWK | 252,046 | $3.2M | 1.12% |
| 29 | MORPHOSYS AG | 617760202 | 896,600 | $3.2M | 1.12% |
| 30 | MERSANA THERAPEUTICS INC | 59045L106 | 460,000 | $2.7M | 0.94% |
| 31 | THESEUS PHARMACEUTICALS INC | 88369M101 | 535,000 | $2.7M | 0.93% |
| 32 | FENNEC PHARMACEUTICALS INC | FENC | 272,200 | $2.6M | 0.91% |
| 33 | IDEAYA BIOSCIENCES INC | IDYA | 138,800 | $2.5M | 0.88% |
| 34 | STEREOTAXIS INC | STXS | 1,185,000 | $2.5M | 0.85% |
| 35 | BIOATLA INC | BCAB | 261,800 | $2.2M | 0.75% |
| 36 | FORTRESS BIOTECH INC | FBIOP | 2,050,000 | $1.3M | 0.47% |
| 37 | ALLAKOS INC | 01671P100 | 153,500 | $1.3M | 0.45% |
| 38 | THERAVANCE BIOPHARMA INC | TBPH | 87,600 | $982,872 | 0.34% |
| 39 | TREVI THERAPEUTICS INC | TRVI | 485,000 | $936,050 | 0.33% |
| 40 | MODULAR MEDICAL INC | MODD | 245,000 | $490,000 | 0.17% |